Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference21 articles.
1. Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting;NV Patrao;Am J Ophthalmol,2016
2. Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice;R Campos Polo;Clin Ophthalmol,2018
3. Diabetic macular edema. A review;GH Bresnick;Ophthalmology,1986
4. Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema;SM Fouda;Clin Ophthalmol,2017
5. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data;F Ziemssen;Int J Retina Vitreous,2016
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-Vascular Endothelial Growth Factor Treatment in Diabetic Macular Edema-Results from a Large Single Center Cohort with Bevacizumab As First-Line Therapy;Retina;2024-03-12
2. Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience;Indian Journal of Ophthalmology;2024-03-08
3. Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study;International Ophthalmology;2023-07-28
4. Real-World Outcomes of Anti-VEGF Therapy in Diabetic Macular Oedema: Barriers to Treatment Success and Implications for Low/Lower-Middle-Income Countries;Ophthalmology and Therapy;2023-02-23
5. Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion;Arquivos Brasileiros de Oftalmologia;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3